Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.

Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW.

J Immunol. 2010 Jun 15;184(12):7144-53. doi: 10.4049/jimmunol.0902739. Epub 2010 May 10.

2.

Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis.

Kochetkova I, Thornburg T, Callis G, Pascual DW.

J Immunol. 2011 Nov 1;187(9):4654-66. doi: 10.4049/jimmunol.1100530. Epub 2011 Oct 3.

3.

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells.

Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY.

Eur J Immunol. 2007 Nov;37(11):3021-9. Erratum in: Eur J Immunol. 2007 Nov;37(11):3293.

4.

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH.

J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.

5.

Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.

Grant CR, Liberal R, Holder BS, Cardone J, Ma Y, Robson SC, Mieli-Vergani G, Vergani D, Longhi MS.

Hepatology. 2014 Mar;59(3):1007-15. doi: 10.1002/hep.26583. Epub 2014 Jan 30.

PMID:
23787765
6.

Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.

Kochetkova I, Thornburg T, Callis G, Holderness K, Maddaloni M, Pascual DW.

J Immunol. 2014 Jan 15;192(2):804-16. doi: 10.4049/jimmunol.1302018. Epub 2013 Dec 11.

7.

Regulatory T cells participate in CD39-mediated protection from renal injury.

Wang YM, McRae JL, Robson SC, Cowan PJ, Zhang GY, Hu M, Polhill T, Wang Y, Zheng G, Wang Y, Lee VW, Unwin RJ, Harris DC, Dwyer KM, Alexander SI.

Eur J Immunol. 2012 Sep;42(9):2441-51. doi: 10.1002/eji.201242434.

8.

Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.

Kim K, Perera R, Tan DB, Fernandez S, Seddiki N, Waring J, French MA.

Tuberculosis (Edinb). 2014 Sep;94(5):494-501. doi: 10.1016/j.tube.2014.07.002. Epub 2014 Jul 17.

PMID:
25095750
9.

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.

Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N.

Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246.

10.

Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.

Asnagli H, Martire D, Belmonte N, Quentin J, Bastian H, Boucard-Jourdin M, Fall PB, Mausset-Bonnefont AL, Mantello-Moreau A, Rouquier S, Marchetti I, Jorgensen C, Foussat A, Louis-Plence P.

Arthritis Res Ther. 2014 May 22;16(3):R115. doi: 10.1186/ar4567.

11.

IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis.

Tao J, Kamanaka M, Hao J, Hao Z, Jiang X, Craft JE, Flavell RA, Wu Z, Hong Z, Zhao L, Yin Z.

Arthritis Res Ther. 2011;13(6):R212. doi: 10.1186/ar3545. Epub 2011 Dec 22.

12.

Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.

Jenabian MA, Seddiki N, Yatim A, Carriere M, Hulin A, Younas M, Ghadimi E, Kök A, Routy JP, Tremblay A, Sévigny J, Lelievre JD, Levy Y.

PLoS Pathog. 2013;9(4):e1003319. doi: 10.1371/journal.ppat.1003319. Epub 2013 Apr 25.

13.

Early events in peripheral regulatory T cell induction via the nasal mucosa.

Unger WW, Hauet-Broere F, Jansen W, van Berkel LA, Kraal G, Samsom JN.

J Immunol. 2003 Nov 1;171(9):4592-603.

14.

CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.

Boer MC, van Meijgaarden KE, Bastid J, Ottenhoff TH, Joosten SA.

Eur J Immunol. 2013 Jul;43(7):1925-32. doi: 10.1002/eji.201243286. Epub 2013 May 29.

15.

Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.

Chen M, Su W, Lin X, Guo Z, Wang J, Zhang Q, Brand D, Ryffel B, Huang J, Liu Z, He X, Le AD, Zheng SG.

Arthritis Rheum. 2013 May;65(5):1181-93. doi: 10.1002/art.37894.

16.

Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

Huang H, Dawicki W, Zhang X, Town J, Gordon JR.

J Immunol. 2010 Nov 1;185(9):5003-10. doi: 10.4049/jimmunol.0903446. Epub 2010 Sep 24.

17.

Milk-based nutraceutical for treating autoimmune arthritis via the stimulation of IL-10- and TGF-β-producing CD39+ regulatory T cells.

Maddaloni M, Kochetkova I, Jun S, Callis G, Thornburg T, Pascual DW.

PLoS One. 2015 Jan 28;10(1):e0117825. doi: 10.1371/journal.pone.0117825. eCollection 2015.

18.

Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.

Peres RS, Liew FY, Talbot J, Carregaro V, Oliveira RD, Almeida SL, França RF, Donate PB, Pinto LG, Ferreira FI, Costa DL, Demarque DP, Gouvea DR, Lopes NP, Queiroz RH, Silva JS, Figueiredo F, Alves-Filho JC, Cunha TM, Ferreira SH, Louzada-Junior P, Cunha FQ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2509-14. doi: 10.1073/pnas.1424792112. Epub 2015 Feb 9.

19.

CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.

Wang LL, Tang HP, Shi GC, Wan HY, Tang W, Hou XX, Pan LN, Shi BY, Tao LQ.

Mol Med Rep. 2013 Nov;8(5):1432-8. doi: 10.3892/mmr.2013.1692. Epub 2013 Sep 18.

PMID:
24065069
20.

Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.

Xia N, Jiao J, Tang TT, Lv BJ, Lu YZ, Wang KJ, Zhu ZF, Mao XB, Nie SF, Wang Q, Tu X, Xiao H, Liao YH, Shi GP, Cheng X.

Clin Sci (Lond). 2015 May 1;128(10):679-93. doi: 10.1042/CS20140672.

PMID:
25558978

Supplemental Content

Support Center